These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 23568616

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.
    Pilcer G, Vanderbist F, Amighi K.
    Int J Pharm; 2009 Jan 05; 365(1-2):162-9. PubMed ID: 18782609
    [Abstract] [Full Text] [Related]

  • 5. Spray-dried carrier-free dry powder tobramycin formulations with improved dispersion properties.
    Pilcer G, Vanderbist F, Amighi K.
    J Pharm Sci; 2009 Apr 05; 98(4):1463-75. PubMed ID: 18752304
    [Abstract] [Full Text] [Related]

  • 6. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
    Li X, Vogt FG, Hayes D, Mansour HM.
    Eur J Pharm Sci; 2014 Feb 14; 52():191-205. PubMed ID: 24215736
    [Abstract] [Full Text] [Related]

  • 7. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW, Li X, Vogt FG, Hayes D, Zwischenberger JB, Park ES, Mansour HM.
    Int J Pharm; 2013 Oct 15; 455(1-2):374-92. PubMed ID: 23820131
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The Cyclops for pulmonary delivery of aminoglycosides; a new member of the Twincer™ family.
    Hoppentocht M, Akkerman OW, Hagedoorn P, Frijlink HW, de Boer AH.
    Eur J Pharm Biopharm; 2015 Feb 15; 90():8-15. PubMed ID: 25615881
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clarithromycin and N-acetylcysteine co-spray-dried powders for pulmonary drug delivery: A focus on drug solubility.
    Manniello MD, Del Gaudio P, Aquino RP, Russo P.
    Int J Pharm; 2017 Nov 30; 533(2):463-469. PubMed ID: 28377314
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Toward Repositioning Niclosamide for Antivirulence Therapy of Pseudomonas aeruginosa Lung Infections: Development of Inhalable Formulations through Nanosuspension Technology.
    Costabile G, d'Angelo I, Rampioni G, Bondì R, Pompili B, Ascenzioni F, Mitidieri E, d'Emmanuele di Villa Bianca R, Sorrentino R, Miro A, Quaglia F, Imperi F, Leoni L, Ungaro F.
    Mol Pharm; 2015 Aug 03; 12(8):2604-17. PubMed ID: 25974285
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection.
    Greenwood J, Schwarz C, Sommerwerck U, Nash EF, Tamm M, Cao W, Mastoridis P, Debonnett L, Hamed K.
    Ther Adv Respir Dis; 2017 Jul 03; 11(7):249-260. PubMed ID: 28614995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.